ASH Impact Series: Vincent Rajkumar, MD - Examining the New FDA Approved Myeloma Drug Products

Vincent Rajkumar, MD, discusses the three myeloma drugs that received FDA approval in November 2015 and how they will affect myeloma therapy. Dr. Rajkumar offered a clinical perspective on the new myeloma drugs at the "ASH/FDA Joint Symposium on Late-Breaking Drug Approvals" at the 57th ASH Annual Meeting. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.